Plainview, NY, United States of America

Richard A Gross

This inventor holds 36 USPTO granted patents and 10 published patent applications and 5 EPO patents, primarily in Biodegradable Polymers. Top assignees: New York University, The Cleveland Clinic Foundation, University of Massachusetts. Active years: 1995-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Richard A Gross. Retrieved from https://idiyas.com/inventor/richard-a-gross-eegf7f1n

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 36 

% Patents Active = 52.8

 

Average Co-Inventor Count = 2.4

ph-index = 9

Forward Citations = 396(Granted Patents)


Location History:

  • Chelmsford, MA (US) (1995 - 1999)
  • Brooklyn, NY (US) (2003 - 2011)
  • New York, NY (US) (2012 - 2014)
  • Plainview, NY (US) (2000 - 2017)

Company Filing History:


Years Active: 1995-2017

Loading Chart...
Loading Chart...
Areas of Expertise:
Sophorolipids
Biodegradable Polymers
Enzyme-Catalyzed Synthesis
Oligomeric Compounds
Hydroxyphenyl Networks
Chitosan Exopolymers
Bioresorbable Copolymers
Transesterifications
Sepsis Treatment
Polycarbonate Esters
Fermentation Medium
Virucidal Properties
36 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Richard A. Gross in the Field of Sophorolipids

Introduction

Richard A. Gross, based in Plainview, NY, is an accomplished inventor with a remarkable portfolio of 36 patents. His work primarily focuses on the development and application of sophorolipids, which are a class of biosurfactants known for their functionality in various industries.

Latest Patents

Among his latest inventions, Gross introduced two noteworthy patents. The first is titled "Modified Sophorolipids as Oil Solubilizing Agents". This patent outlines a method for creating a library of modified sophorolipids using a variety of chemical and enzyme catalyst tools. These modified sophorolipids have applications in solubilizing, emulsifying, and dispersing diverse oil types and nutraceuticals.

The second patent is known as "Sophorolipid Analog Compositions". This composition encompasses sophorolipids used as antimicrobial agents, antifungal agents, and biopesticides. It highlights their potential as therapeutic agents for conditions such as HIV, septic shock, cancer, and asthma. Additionally, these compounds serve roles as anti-inflammatory drugs, ingredients in cosmetics, and building blocks for both monomers and polymers.

Career Highlights

Richard A. Gross has had a significant career with impactful contributions to scientific innovation. He has worked with esteemed institutions, including the Cleveland Clinic Foundation, where he focused on advancing biotechnological solutions that leverage the potential of sophorolipids.

Collaborations

Throughout his career, Gross has collaborated with notable individuals such as Anthony Calabro and Aniq B. Darr. These partnerships have been instrumental in the successful development and implementation of his innovative approaches in the field of biosurfactants.

Conclusion

Richard A. Gross exemplifies the spirit of innovation through his extensive research and development of sophorolipids. His groundbreaking patents continue to influence various applications across sectors, establishing him as a leading inventor on the frontier of biotechnology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…